Enterovirus 71 meningoencephalitis complicating rituximab therapy

J Neurol Sci. 2011 Jun 15;305(1-2):149-51. doi: 10.1016/j.jns.2011.03.009. Epub 2011 Mar 27.

Abstract

We describe a fatal case of proven enterovirus 71 meningoencephalitis complicating monoclonal anti-CD20 antibody therapy for non-Hodgkin's lymphoma. B-cell depletion, an effective treatment strategy in an expanding spectrum of hematological and inflammatory disorders, impairs neutralising antibody-mediated clearance of enterovirus. The global threat of emerging neurotropic viruses such as enterovirus 71 is heightened by an increasing pool of susceptible individuals in non-endemic regions.

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / adverse effects*
  • Antineoplastic Agents / adverse effects
  • Enterovirus A, Human / immunology*
  • Enterovirus Infections / complications
  • Enterovirus Infections / immunology*
  • Fatal Outcome
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Male
  • Meningoencephalitis / physiopathology
  • Meningoencephalitis / virology*
  • Middle Aged
  • Rituximab

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Immunosuppressive Agents
  • Rituximab